Gadolinium-based nanoscale MRI contrast agents for tumor imaging
- 28 March 2017
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 5 (19) , 3431-3461
Abstract
Gadolinium-based nanoscale MRI CAs have been considered as a promising nanoplatform for tumor diagnosis, due to their favorable capability of enhancing the longitudinal relaxivity (r1) of individual gadolinium ions, delivering to the region of interest a large number of gadolinium ions, and incorporating different functionalities.Keywords
Funding Information
- National Natural Science Foundation of China (21575154)
This publication has 162 references indexed in Scilit:
- Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imagingBiomaterials, 2013
- A Synergistically Enhanced T1–T2 Dual‐Modal Contrast AgentAdvanced Materials, 2012
- MRI monitoring of intratumoral drug delivery and prediction of the therapeutic effect with a multifunctional thermosensitive liposomeBiomaterials, 2011
- A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivityBiomaterials, 2011
- A Responsive Europium(III) Chelate That Provides a Direct Readout of pH by MRIJournal of the American Chemical Society, 2010
- Multimodality Imaging Probes: Design and ChallengesChemical Reviews, 2010
- Porous Polymersomes with Encapsulated Gd‐Labeled Dendrimers as Highly Efficient MRI Contrast AgentsAdvanced Functional Materials, 2009
- Nanodelivery of MRI Contrast Agent Enhances Sensitivity of Detection of Lung Cancer MetastasesAcademic Radiology, 2009
- Micelles Based on Biodegradable Poly(l-glutamic acid)-b-Polylactide with Paramagnetic Gd Ions Chelated to the Shell Layer as a Potential Nanoscale MRI−Visible Delivery SystemBiomacromolecules, 2007
- Nanoscale Metal−Organic Frameworks as Potential Multimodal Contrast Enhancing AgentsJournal of the American Chemical Society, 2006